BELSOMRA 20 mg/1

Suvorexant, the active ingredient in BELSOMRA 20 mg/1, is a dual orexin receptor antagonist presented as a 20 mg/1 film-coated tablet for oral use. It is used to treat insomnia, specifically difficulty falling asleep and/or staying asleep, in adults. GNH USA supplies BELSOMRA 20 mg/1 as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide.

BELSOMRA 20 mg/1 is a prescription medication designed to improve sleep quality by targeting specific receptors in the brain. It is important to follow the prescribed dosage and consult healthcare providers for any concerns or side effects.

BELSOMRA 20 mg/1 is used to treat insomnia, a sleep disorder characterized by difficulty falling or staying asleep. It works by targeting specific receptors in the brain to promote sleep.

- Insomnia: Helps individuals fall asleep faster and stay asleep longer. - Sleep maintenance: Improves the ability to maintain restful sleep throughout the night. - Sleep onset: Reduces the time it takes to fall asleep.

BELSOMRA 20 mg/1 may cause various side effects, ranging from common to serious. It is important to be aware of these potential effects and consult a healthcare provider if they occur.

Common Side Effects: - Drowsiness: Feeling sleepy during the day. - Headache: Mild to moderate pain in the head. - Dizziness: A sensation of lightheadedness or unsteadiness. - Abnormal dreams: Unusual or vivid dreams. - Dry mouth: A feeling of dryness in the mouth. - Upper respiratory tract infections: Symptoms such as cough or sore throat.

Serious or Rare Side Effects: - Worsening depression: Increased feelings of sadness or hopelessness. - Suicidal thinking: Thoughts of harming oneself. - Behavioral changes: Unusual or aggressive behavior. - Sleep paralysis: Temporary inability to move or speak while falling asleep or waking up. - Cataplexy: Physical collapse while remaining conscious. - Sleep driving: Performing activities such as driving while not fully awake.

BELSOMRA 20 mg/1 should be used with caution, and certain precautions should be taken to ensure safe and effective use. Consult a healthcare provider for personalized advice.

- Avoid alcohol: Do not drink alcohol while taking BELSOMRA, as it can worsen side effects. - Driving and machinery: Do not drive or operate heavy machinery within 8 hours of taking BELSOMRA. - Daytime drowsiness: Be cautious of drowsiness and decreased mental alertness the day after taking BELSOMRA. - Mental health: Monitor for changes in behavior, mood, or mental health while taking BELSOMRA. - Pregnancy and breastfeeding: Consult a healthcare provider before using BELSOMRA if pregnant or breastfeeding. - Storage: Store below 25°C: keep in the original pack, protect from moisture.

BELSOMRA 20 mg/1 may interact with other medications, alcohol, and certain medical conditions. It is important to inform your healthcare provider about all medications and conditions before starting BELSOMRA.

Major Interactions (Avoid): - Alcohol: Increases the sedative effects of BELSOMRA. - Azole antifungals: May increase blood levels of BELSOMRA. - Protease inhibitors: Can raise the concentration of BELSOMRA in the blood. - Certain antibiotics: May interact with BELSOMRA, leading to increased side effects.

Moderate Interactions (Monitor Closely): - Rifampin: May reduce the effectiveness of BELSOMRA. - Carbamazepine: Can decrease the blood levels and effect of BELSOMRA. - Phenytoin: May reduce the effectiveness of BELSOMRA. - Digoxin: BELSOMRA may increase blood levels of digoxin.